BC-LI-0186

BC-LI-0186 is a compound that acts as an inhibitor of the GTPase enzyme leucyl-tRNA synthetase (LRS). This enzyme acts as part of the mTOR complex and acts as a leucine sensor which stimulates mTORC1 in the presence of leucine. BC-LI-0186 blocks the docking site for mTORC1 and thereby prevents the mTOR activation and increased protein synthesis which is usually triggered by branched-chain amino acids such as leucine, yet without inhibiting the separate catalytic activity of LRS.^[1] This may have potential applications in the treatment of cancer,^[2] and BC-LI-0186 has also been shown to promote muscle regeneration after injury.^[3]

BC-LI-0186

Identifiers
IUPAC name 4-(2,3-dimethyl-5-oxo-4-propan-2-ylpyrazol-1-yl)-N-(2-phenoxyethyl)benzenesulfonamide
CAS Number	695207-56-8
PubChem CID	4917788
ChemSpider	4099704
CompTox Dashboard (EPA)	DTXSID901336671
Chemical and physical data
Formula	C22H27N3O4S
Molar mass	429.54 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1=C(C(=O)N(N1C)C2=CC=C(C=C2)S(=O)(=O)NCCOC3=CC=CC=C3)C(C)C
InChI InChI=1S/C22H27N3O4S/c1-16(2)21-17(3)24(4)25(22(21)26)18-10-12-20(13-11-18)30(27,28)23-14-15-29-19-8-6-5-7-9-19/h5-13,16,23H,14-15H2,1-4H3 Key:SQYWMHPZMHDCHP-UHFFFAOYSA-N